Searched for
AKUMS DRUGS LISTING
Ahead of Market: 10 things that will decide stock market action on MondayMarkets rallied sharply as easing US–Iran tensions and softer crude prices boosted sentiment. Sensex and Nifty surged 2%, adding Rs 10 lakh...- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Shares worth Rs 80,000 crore to exit IPO lock-inBankers and brokers said a chunk of these shares could flood the market as various investors would look to book profits with the stock mark...
- 43 newly-listed companies in focus ahead of $18.8 billion lock-in expiry43 companies have pre-listing shareholder lock-ins expiring by December 31, unlocking shares worth USD 18.8 billion. However, not all share...
- IPO lock-in expires, shares of 38 companies worth $21 billion may enter market by NovemberBetween now and November 30, $21 billion worth of shareholder lock-ins across 38 companies will expire. This includes shares from Ceigall I...
- Akum Drugs shares tumble 5% despite posting Rs 60 crore Q1 profitAkum Drugs Share Price: Akum Drugs and Pharmaceuticals' shares dropped 5% to Rs 895 despite reporting a Rs 60 crore net profit for the June...
- Ceigall India IPO share allotment soon: Check status, GMP, listing date and other detailsThe Ceigall India IPO share allotment was determined, with shares given out through a lottery system overseen by Link Intime India. Investo...
- Akums Drugs and Pharma shares jump 8% post listing. Should you buy, sell or hold?Akums Drugs and Pharmaceuticals saw its shares rise 8% to Rs 784.6 on its debut, despite a strong subscription rate of 63.44 times. Analyst...
- Akums Drugs and Pharma shares list at 7% premium over issue priceAkums Drugs and Pharmaceuticals' shares began trading at Rs 725, a 6.8% premium over the issue price of Rs 679, after an IPO that was subsc...
- Ceigall India IPO subscribed 13.78 times on last day of bidding process. Check GMP and other detailsHighest demand was driven by qualified institutional buyers as the portion was booked 31.5 times, followed by the non-institutional investo...
- Akums Drugs and Pharma shares to list on Tuesday. Here's what GMP suggestsAkums Drugs and Pharmaceuticals will debut on Tuesday. The stock, with a GMP of Rs 140, is expected to list at a 21% premium over the upper...
- Akums Drugs & Pharma IPO share allotment to be finalised today: Check status, GMP, listing date and other detailsAkums Drugs & Pharma share allotment has been finalised. Shares will be out on August 6. The IPO was subscribed 63.5 times. Proceeds will a...
- Akums Drugs and Pharma IPO: Check subscription on Day 3, GMP and other detailsNon-institutional investors subscribed 22.8 times, followed by retail investors, whose category was booked 13.8 times. The part reserved fo...
- Akums Drugs and Pharma IPO opens tomorrow: Price band, GMP among 10 things to know before subscribingAkums Drugs and Pharma's IPO, open from July 30 to August 1, targets raising Rs 1857 crore. The company specializes in pharmaceutical devel...
- IPO Calendar: 8 IPOs, 11 listings investors need to watch out for next weekAnalysts said India's capital markets are playing a vital role in the country's growth, thanks to advancements in technology, innovation, a...
- Akums Drugs and Pharmaceuticals Rs 1,857 crore IPO opens Tuesday. Check price band, other detailsAkums Drugs and Pharmaceuticals' Rs 1,857 crore IPO opened from July 30 to August 1, featuring a Rs 680 crore fresh issue and 1.73 crore sh...
- Akums Drugs and Pharma IPO: Co to raise ₹1,857 crore at price band of Rs 646-679/share; issue opens on July 30Akums Drugs and Pharma IPO: Akum Drugs and Pharmaceuticals set a price band of Rs 646 to Rs 679 per share for its IPO, aiming to raise Rs 1...
- Why the health of India’s $50-billion pharma industry depends on ChinaThe country’s dependence on imports of raw materials to make medicines is at a disconcerting level now, especially with the government focu...
- Akums Drugs ties up with Microcore Research to manufacture NESM supplementsAkums will leverage NESM and develop dietary supplements for maintaining healthy joint and connective tissues.
- Piramal, Cadila among 32 companies in race to buy Sharon Bio-MedicineSome fund houses, including iLabs India Special Situations Fund, Edelweiss Alternative Assets Advisors, Capri Global Holdings, ACRE India, ...
Load More
